An Aston University researcher has developed a new technique using light which could revolutionize non-invasive medical diagnostics and optical communication. The research showcases how a type of ...

REDMOND, Wash.--(BUSINESS WIRE)--Anavasi Diagnostics, an NIH/RADx funded medical technology company developing novel molecular diagnostic testing for the point-of-care (POC) market, announced the Food ...

The AI-powered precision cardiovascular medicine company is launching PrecisionCHD, a new blood test for the early detection of coronary heart disease. Chicago health ...

Coverage marks a pivotal step in expanding access to ultra-sensitive MRD detection for breast cancer patients U.S. Medicare coverage decision reflects published, peer-reviewed clinical data ...

Globally, more than half of patients die after infection with the neglected tropical disease, melioidosis, often before they are diagnosed. A new rapid test could save lives by diagnosing patients in ...

Researchers have developed sponge-like gold nanoparticles that can be used to highlight ovarian cancer markers in samples of ...

The FDA’s approval on Thursday for BioMarin’s Roctavian gene therapy for severe hemophilia A came with a second approval attached: for a companion diagnostic that can identify which patients may be ...

LightDeck Diagnostics, the trade name for medical test maker mBio Diagnostics Inc., has elevated executive vice president of corporate development Nick Traggis to CEO. Former CEO Chris Myatt will take ...